ANIXA BIOSCIENCES, INC. Unrecognized Tax Benefits, Income Tax Penalties Accrued
ANIXA BIOSCIENCES, INC. (ANIX) had Unrecognized Tax Benefits, Income Tax Penalties Accrued of $0 as of 2025-10-31, per its 10-K filed 2026-01-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued · last filed 2026-01-12
- 2025-10-31: Unrecognized Tax Benefits, Income Tax Penalties Accrued $0.00.
- 2024-10-31: Unrecognized Tax Benefits, Income Tax Penalties Accrued $0.00.
- 2024-04-30: Unrecognized Tax Benefits, Income Tax Penalties Accrued $0.00.
- 2024-01-31: Unrecognized Tax Benefits, Income Tax Penalties Accrued $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties Accrued |
|---|---|
| 2025-10-31 | $0.00 10-K · filed 2026-01-12 |
| 2024-10-31 | $0.00 10-K · filed 2026-01-12 |
| 2024-04-30 | $0.00 10-Q · filed 2024-06-04 |
| 2024-01-31 | $0.00 10-Q · filed 2024-03-12 |
| 2023-10-31 | $0.00 10-K · filed 2025-01-10 |
| 2023-07-31 | $0.00 10-Q · filed 2023-09-06 |
| 2023-04-30 | $0.00 10-Q · filed 2023-06-14 |
| 2023-01-31 | $0.00 10-Q · filed 2023-03-17 |
| 2022-10-31 | $0.00 10-K · filed 2024-01-16 |
| 2022-07-31 | $0.00 10-Q · filed 2022-09-09 |
| 2022-04-30 | $0.00 10-Q · filed 2022-06-10 |
| 2022-01-31 | $0.00 10-Q · filed 2022-03-11 |
| 2021-10-31 | $0.00 10-K · filed 2023-01-04 |
| 2021-07-31 | $0.00 10-Q · filed 2021-09-01 |
| 2020-10-31 | $0.00 10-K · filed 2022-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |